This promotional webinar series has been commissioned by Ipsen and is intended for UK healthcare professionals. Products and brands may be mentioned.
Impact of COVID-19 on urology services and prostate cancer care: where do we go from here?
Online | 28 October 2021 @ 7pm
Practical approaches to medicine use for prostate cancer management in primary care during the pandemic
Online | Coming soon
Click to view prescribing information for Decapeptyl® SR (triptorelin) 3mg, Decapeptyl® SR (triptorelin) 11.25mg and Decapeptyl® SR (triptorelin) 22.5mg.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Ipsen via email at firstname.lastname@example.org
or phone on 01753 627777.
September 2021: TRI-UK-004704